A gene variant in the cannabinoid receptor influenced how THC affected brain attention signals
A specific repeat polymorphism in the CNR1 cannabinoid receptor gene modulated how THC affected the P300 brain wave, a marker of attention and working memory.
Quick Facts
What This Study Found
Twenty healthy volunteers received oral THC, cannabis extract (THC + CBD), or placebo in a controlled study. Both THC and cannabis extract reduced P300 amplitudes (a brain wave associated with attention and working memory), with no difference between the two cannabinoid conditions.
However, when participants were grouped by their CNR1 gene variant (an AAT repeat polymorphism), those with the >10/>10 genotype showed a significant P300 amplitude decrease and latency prolongation specifically under pure THC, but not under cannabis extract containing both THC and CBD.
The number of AAT repeats correlated with P300 changes under THC, suggesting the cannabinoid receptor gene directly influenced sensitivity to THC's cognitive effects.
Key Numbers
20 healthy volunteers. CNR1 (AAT)n repeat polymorphism genotyped. >10/>10 genotype showed significant P300 changes under THC but not cannabis extract. Number of AAT repeats correlated with THC-induced P300 changes.
How They Did This
Study of 20 healthy volunteers genotyped for the CNR1 (AAT)n polymorphism. Participants received oral THC, cannabis extract (THC + CBD), or placebo. EEG P300 was recorded during an auditory choice reaction task.
Why This Research Matters
This was early evidence that genetic variation in the cannabinoid receptor gene could explain why people respond differently to cannabis. The finding that CBD in the extract appeared to buffer the genetic sensitivity to pure THC was also notable.
The Bigger Picture
The same CNR1 polymorphism had been associated with both schizophrenia and substance dependence. This study connected those genetic findings to a specific cognitive mechanism, potentially explaining why some individuals are more vulnerable to cannabis-related cognitive effects and psychosis risk.
What This Study Doesn't Tell Us
Very small sample size (20 volunteers) limits genetic analysis power. A single genetic variant was examined. The study could not determine whether the genotype effect has real-world cognitive consequences beyond EEG changes.
Questions This Raises
- ?Does the CNR1 polymorphism predict real-world cognitive impairment from cannabis?
- ?Could genetic testing identify individuals at higher risk for adverse cannabis effects?
- ?Does CBD genuinely protect against genotype-specific THC sensitivity?
Trust & Context
- Key Stat:
- CNR1 genotype predicted sensitivity to THC effects on attention
- Evidence Grade:
- Small RCT with genetic subgroup analysis. Exploratory pharmacogenomic study with interesting findings but insufficient sample size for definitive conclusions.
- Study Age:
- Published in 2011. Cannabis pharmacogenomics has expanded but remains an early-stage field.
- Original Title:
- Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential.
- Published In:
- Neuroscience letters, 496(1), 60-4 (2011)
- Authors:
- Stadelmann, Andreas M(3), Juckel, Georg(5), Arning, Larissa, Gallinat, Jürgen, Epplen, Jörg T, Roser, Patrik
- Database ID:
- RTHC-00526
Evidence Hierarchy
Participants are randomly assigned to treatment or placebo groups to test cause and effect.
What do these levels mean? →Frequently Asked Questions
Can your genes determine how cannabis affects you?
This study found that a specific variant in the cannabinoid receptor gene (CNR1) influenced how THC affected attention-related brain waves. People with certain versions of this gene showed more pronounced cognitive effects from pure THC.
Did CBD make a difference based on genetics?
People with the sensitive genotype showed significant P300 changes under pure THC but not under cannabis extract containing both THC and CBD. This suggested CBD may buffer the genetic sensitivity, though the sample was too small to be definitive.
Read More on RethinkTHC
- cannabis-cardiovascular-heart-risk-stroke
- cannabis-heart-cardiovascular-risk
- coughing-up-stuff-after-quitting-weed
- lung-recovery-after-quitting-smoking-weed
- lung-recovery-quitting-weed
- quitting-weed-female-hormones
- quitting-weed-weight-gain-loss-diet-appetite
- sex-after-quitting-weed
- weed-DUI-driving-impaired-cannabis-laws
- weed-acne-skin
- weed-fertility-sperm
- weed-gut-digestion-problems
- weed-heart-health
- weed-testosterone-levels
Cite This Study
https://rethinkthc.com/research/RTHC-00526APA
Stadelmann, Andreas M; Juckel, Georg; Arning, Larissa; Gallinat, Jürgen; Epplen, Jörg T; Roser, Patrik. (2011). Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential.. Neuroscience letters, 496(1), 60-4. https://doi.org/10.1016/j.neulet.2011.04.003
MLA
Stadelmann, Andreas M, et al. "Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential.." Neuroscience letters, 2011. https://doi.org/10.1016/j.neulet.2011.04.003
RethinkTHC
RethinkTHC Research Database. "Association between a cannabinoid receptor gene (CNR1) polym..." RTHC-00526. Retrieved from https://rethinkthc.com/research/stadelmann-2011-association-between-a-cannabinoid
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.